These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21244547)

  • 1. Management of attention-deficit/hyperactivity disorder: the importance of psychosocial and medication treatments.
    Vance A; Winther J; Rennie K
    J Paediatr Child Health; 2012 Feb; 48(2):E33-7. PubMed ID: 21244547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pearls, perils, and pitfalls in the assessment and treatment of attention-deficit/hyperactivity disorder in adolescents.
    Obioha O; Adesman A
    Curr Opin Pediatr; 2014 Feb; 26(1):119-29. PubMed ID: 24370490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.
    Levin H; Hanten G; Max J; Li X; Swank P; Ewing-Cobbs L; Dennis M; Menefee DS; Schachar R
    J Dev Behav Pediatr; 2007 Apr; 28(2):108-18. PubMed ID: 17435461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention-deficit/hyperactivity disorder: are we medicating for social disadvantage? (Against).
    Efron D
    J Paediatr Child Health; 2006 Sep; 42(9):548-51. PubMed ID: 16925543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial treatments for preschool-aged children with Attention-Deficit Hyperactivity Disorder.
    Laforett DR; Murray DW; Kollins SH
    Dev Disabil Res Rev; 2008; 14(4):300-10. PubMed ID: 19072758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P; Hsu HY; Chiou SS; Chao MC
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder.
    Pliszka S;
    J Am Acad Child Adolesc Psychiatry; 2007 Jul; 46(7):894-921. PubMed ID: 17581453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of treatment refractory attention-deficit/hyperactivity disorder in children and adolescents.
    Wagner KD
    Psychopharmacol Bull; 2002; 36(1):130-42. PubMed ID: 12397852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
    NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The significance of attention-deficit hyperactivity disorder for the future of the child and the young].
    Penttilä J; Rintahaka P; Kaltiala-Heino R
    Duodecim; 2011; 127(14):1433-9. PubMed ID: 21888044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention-deficit/hyperactivity disorder: are we medicating for social disadvantage? (For).
    Isaacs D
    J Paediatr Child Health; 2006 Sep; 42(9):544-7. PubMed ID: 16925542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulant and psychosocial treatment of ADHD in Latino/Hispanic children.
    Bauermeister JJ; Canino G; Bravo M; Ramírez R; Jensen PS; Chavez L; Martínez-Taboas A; Ribera J; Alegría M; García P
    J Am Acad Child Adolesc Psychiatry; 2003 Jul; 42(7):851-5. PubMed ID: 12819445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal treatment for childhood attention-deficit/hyperactivity disorder.
    Kaiser NM; Hoza B; Hurt EA
    Expert Rev Neurother; 2008 Oct; 8(10):1573-83. PubMed ID: 18928349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are stimulants overprescribed? Treatment of ADHD in four U.S. communities.
    Jensen PS; Kettle L; Roper MT; Sloan MT; Dulcan MK; Hoven C; Bird HR; Bauermeister JJ; Payne JD
    J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):797-804. PubMed ID: 10405496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder.
    Kariyawasam SH; Zaw F; Handley SL
    Neuro Endocrinol Lett; 2002 Feb; 23(1):45-8. PubMed ID: 11880861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.